Skip to main content

PNC FINANCIAL SERVICES GROUP, INC.

Position in DNLI — Denali Therapeutics Inc.

CIK 713676 Pittsburgh, PA

Position in DNLI

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$234,616
+$57,594 QoQ
Shares Held
9,122
-1.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#188
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 93% Shared 7% None 0%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $113,274,406 across 262 Biotechnology names. DNLI ranks #52 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $234,616 9,122
2026-03-31 $177,022 9,220
2025-12-31 $140,020 8,481
2025-09-30 $120,369 8,290
2025-06-30 $115,221 8,236
2025-03-31 $50,870 3,742
2024-12-31 $77,238 3,790
2024-09-30 $84,620 2,905
2024-06-30 $55,005 2,369
2024-03-31 $33,958 1,655
2023-12-31 $53,348 2,486
2023-09-30 $34,637 1,679
2023-06-30 $58,162 1,971
2023-03-31 $33,545 1,456
2022-12-31 $46,413 1,669
2022-09-30 $27,651 901
2022-06-30 $24,072 818
2022-03-31 $26,957 838
2021-12-31 $64,759 1,452
2021-09-30 $61,094 1,211
2021-06-30 $72,870 929
2021-03-31 $52,360 917
2020-12-31 $77,645 927
2020-09-30 $33,106 924
2020-06-30 $22,342 924
2020-03-31 $16,056 917